Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Thyroid Neoplasms 1Sarcoma, Ewing 1Pain 1Osteosarcoma 1Osteonecrosis 1Nasopharyngeal Carcinoma 1Motor Activity 1Lymphoma, Non-Hodgkin 1Lymphedema 1Leukemia 1Hodgkin Disease 1Exostoses, Multiple Hereditary 1Deglutition Disorders 1Colonic Neoplasms 1Chondrosarcoma 1Breast Neoplasms 1Bone Neoplasms 1Anemia, Sickle Cell 1

Interventions

Cisplatin 127Gemcitabine 71Radiotherapy, Intensity-Modulated 61toripalimab 39Capecitabine 37Docetaxel 36Fluorouracil 35Radiotherapy 24camrelizumab 23Drug Therapy 22nimotuzumab 18spartalizumab 13pembrolizumab 13nedaplatin 12Chemoradiotherapy 12sintilimab 11apatinib 11Induction Chemotherapy 11Immune Checkpoint Inhibitors 11tislelizumab 10Nivolumab 10Magnetic Resonance Spectroscopy 10Specimen Handling 9Radiation 9Cetuximab 9Carboplatin 9endostar protein 8Paclitaxel 8Bevacizumab 8anlotinib 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Nasopharyngeal Carcinoma × Range of Motion, Articular × Clear all
NCT00815087 2014-03-26

Functional Electrical Stimulation in Irradiated Nasopharyngeal Carcinoma (NPC)

National Taiwan University Hospital

Phase 2 Completed
20 enrolled 6 charts
Head & Neck

Nasopharyngeal Carcinoma, Deglutition Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡